PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Endocrinology and Metabolism, The UCSF Metabolic Bone Clinic, University of California-San Francisco, 513 Parnassus Ave, San Francisco, CA, USA.\', \'International FOP Association (IFOPA), North Kansas City, MO, USA.\', \'BioSAS Consulting, Inc., Wellesley, MA, USA.\', \'Division of Endocrinology and Metabolism, Zuckerberg San Francisco General Hospital, San Francisco, CA, USA.\', \'Division of Endocrinology and Metabolism, The UCSF Metabolic Bone Clinic, University of California-San Francisco, 513 Parnassus Ave, San Francisco, CA, USA. Edward.hsiao@ucsf.edu.\', \'The Institute for Human Genetics, The Program in Craniofacial Biology, and the Robert L. Kroc Chair in Rheumatic and Connective Tissue Diseases III, University of California-San Francisco, San Francisco, CA, USA. Edward.hsiao@ucsf.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13023-022-02246-4
?:hasPublicationType
?:journal
  • Orphanet journal of rare diseases
is ?:pmid of
?:pmid
?:pmid
  • 35246171
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.413
?:rankingScore_hIndex
  • 84
is ?:relation_isRelatedTo_publication of
?:title
  • Social and clinical impact of COVID-19 on patients with fibrodysplasia ossificans progressiva.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all